NR2F6 overexpression promotes hepatic TG accumulation in healthy mice, while knockdown of NR2F6 improved hepatosteatosis in obese mice and MCD‐diet induced NASH mice. This evidence concerns the gene NR2F6 and metabolic dysfunction-associated steatohepatitis.